Dysregulation of long non-coding RNAs (lncRNAs) is reported to be associated with the development and progression of various cancers. XIAP-AS1 is a novel lncRNA. It has been shown that XIAP-AS1 is transcribed from the first intron of the complementary strand of the XIAP gene. XIAP-AS1 is located primarily in the nucleus. LncRNA XIAP-AS1 can regulate apoptosis in gastric cancer and might serve as a potential oncogene for colon cancer. Sp1 is a responsible transcription factor for transcription of the XIAP gene. XIAP-AS1 RNA interacts with Sp1 and thereby participates in XIAP transcription. XIAP-AS1 knockingdown decreases the binding of Sp1 to the promoter region of XIAP. In gastric tumor cells, XIAP-AS1 knockdown promotes tumor necrosis factor (TNF)- related apoptosis-inducing ligand (TRAIL)-induced apoptosis. XIAP-AS1 knockdown blockes cell invasion of colon cancer cells by regulating the expression of EMT markers, such as E-cadherin, ZO-1, vimentin, and N-cadherin. Moreover, XIAP-AS1 knockdown significantly reduces STAT3 phosphorylation. XIAP-AS1 interacts with Sp1 and is involved in XIAP transcription. In gastric cancer cells, XIAP-AS1 is a potential target for TRAIL-induced apoptosis. XIAP-AS1 is significantly increased in CRC tissues and moreover its expression showes a positive correlation with TNM stage and cumulative survival rate of CRC. In this review, we focus on the importance of new lncRNA XIAP-AS1 in tumorigenesis, as it functions in apoptosis.
Relevance: Mesenchymal stem cells (MSCs), when cultivated in adherence to plastic surfaces, develop large bundles of actin filaments with mechanosensitive properties. These stress fibers induce tension forces via focal adhesions bound to the extracellular matrix, thereby influencing elastic properties of the cell membrane relevant for MSC function. Methods: Actin was quantified in plastic adherent MSCs or in aggregate cultures using flow cytometry andWestern blotting. Stress fiber formation, connection to focal adhesions and mitochondrial dynamics were investigated by laser scanning microscopy. Surface morphology and membrane properties of MSCs were performed by atomic force microscopy and migration was measured in a wound closure assay. Results: Total actin protein remained largely unchanged during cultivation of MSCs from passage (P)1 to P3, but distribution of bold stress fibers changed. Ventral stress fibers, anchored at each end to focal adhesions, increased in fiber length during cultivation, while dorsal stress fibers anchored at one end to focal adhesions, increased in number. Mitochondrial branching during cultivation from P1 to P3 gave further evidence for deficits in fusion/fission kinetics. Deflection scanning by AFM confirmed these observations by showing intense bundles of stress fibers in P1 andP3 MSCs, while MSC emerging from aggregates showed discrete stress fiber morphology. Force vs indentation profiles of native MSCs with exclusion of nuclear regions showed the highest Young’s moduli of 8.5 ± 6.4 kPa in P1, followed by 6.5 ± 6.1 kPa in P3 MSCs and 3.6 ± 3.2 kPa for MSCs of spherical aggregates. Conclusion: When MSCs are expanded for potential therapeutic use, stress fiber morphology with increased length of ventral stress fibers and higher number of dorsal stress fibers can increase the inner force of MSCs resulting in changes of their physical properties. Mitochondrial branching in passaged MSCs gave further evidence for a decline in cell function.
Pancreas is the essential part to manage the vitality utilization and digestion and is made out of two functionally and morphologically different parts: the endocrine pancreas (islets of Langerhans) and the exocrine pancreas ( ductal cells). The preservation of live pancreatic tissue cuts is an controling tool for the cross examination of pathology and physiology in an in vitro setting that holds cytoarchitecture. Nonetheless, present culture situation for human pancreatic slices (HPSs) have just been tried for short-lived applications, which are not lenient for longitudinal, long-term investigation of pancreatic regeneration. It is exhibited high feasibility and conserved exocrine and endocrine capacity in HPS for minimum 10 days subsequent to segmenting. Human islets have restricted regenerative capacity; loss of the islet Beta-cells in sicknesses, for example, type 1 diabetes requires beneficial therapeutics intercession. The important procedure for reclamation of beta-cell mass is through the transplantation and generation of new Beta-cells got from the human pluripotent stem cells. This innovation is likely to be of extraordinary effect for the lead of constant therapeutics developmental/regeneration for human pancreatic regeneration.
Human mesenchymal stem cells (hMSCs) are considered an ideal strategy for tissue engineering and regenerative medicine. However, their acquisition, administration route, and cell quantity are true challenges. On the other hand, the collagen scaffolds are a viable option, mimicking the extracellular matrix, utilizing collagen as the main polymer in 3D supports. The combination of hMSCs and scaffolds could enable the hMSCs to arrive at the target organ, avoiding the disadvantages of intravenous or intra-arterial therapy. We obtain and characterize MSCs from human amniotic membranes and evaluate their differentiation capacity in 3D collagen matrix scaffolds (CMSs). Their morphology, multipotency genes by RT-PCR and markers by flow cytometry were evaluated in in vitro cell cultures. The differentiation capacity of AM-hMSCs, seeded with and without CMSs, was evaluated in media specific for chondrogenic, osteogenic, and adipogenic lineages. AM-hMSCs were studied up to passage 5 and fibroblastoid morphology was observed in AM-hMSCs and BM-hMSCs. Sox2 gene expression was similar in all passages, whereas oct4 was upregulated at P2 and P5. Nanog was upregulated at P1 and P3 versus BM-hMSCs. Membrane markers displayed CD44, CD73, CD90, and CD105 were positive in all passage. AM-MSCs were adhered to CMSs, showing fibroblastoid morphology in the SEM analyses. The AMhMSCs, seeded with and without CMSs, were able to differentiate into chondroblasts, osteoblasts, and adipocytes. The CMSs enable AM-MSC stemness preservation, without affecting their differentiation capacity. That combination can be a novel strategy in the tissue regeneration process.
Background: Acute myocardial infarction (AMI) induces a pro-inflammatory status of the intramyocardial vasculature in which N?-(carboxymethyl)lysine (CML), an advanced glycation end product, and NOX2, a source of reactive oxygen species (ROS), play an important role. As such they form attractive therapeutic targets to prevent future heart failure development. Previously, we found that adipose tissue derived stem cells coupled to antibody-targeted microbubbles (the so-called StemBells (StB)) improved cardiac function when administered intravenously, also when applied early after AMI in a rat model. Its effect on the intramyocardial microvasculature however is unknown. In the present study we have analyzed its effect on both CML and NOX2 depositions in the intramyocardial vasculature in a rat AMI model. Methods: AMI was induced by ligation of the left coronary artery followed by reperfusion in male Wistar rats. In a subset of these rats, intravenous StB were administered at day 1 [n=8] (group StB day 1), day 7 [n= 7] (group StB 7) or days 1 and 7 [n=7] (group StB day 1+7) post-AMI. Animals were sacrificed at day 42 post-AMI. The effect on CML (immunohistochemical score and/or the number of blood vessels with different intensity scores) and NOX2 positivity (the number of positive blood vessels) was then analyzed using immunohistochemistry. Results: AMI induced a significant increase in both CML (from 0.08 ± 0.01 /mm2 in controls up to 0.3 ± 0.05/mm2 in the AMI group) and NOX2 positivity of the intramyocardial vasculature (from 0.1 ± 0.01 in non-infarcted control rats to 0.53 ± 0.08 in AMI rats). StB therapy significantly decreased NOX2 (0.11 ± 0.02 treated on day 1 post-AMI, 0.19 ± 0.02 when treated on day 7 post-AMI and 0.25 ± 0.04 with administration at day 1 and day 7 post-AMI), without significant differences between the three StB groups) and CML positivity (immunohistochemical score: 0.13 ± 0.03 when treated at day 1 post-AMI, 0.17 ± 0.02 when treated on day 7 post-AMI and 0.13 ± 0.01 with treatment on day 1 and day 7 post-AMI) of the intramyocardial vasculature in all three groups. A significant decreasing effect of StB therapy on the lowest CML intensity (score 1) was found in all three StB groups, on the intermediate (score 2) in the StB day 7 and StB day 1+7 group, and finally on the highest CML intensity (score 3) in the StB day 1+7 group only. Conclusion: StB therapy reduced the pro-inflammatory status of the intramyocardial vasculature post- AMI when applied in the acute phase post-AMI.
Coronavirus disease (COVID-19) is a new strain of coronavirus which is not ceasing to emerge its newer and newer variants with time. The virus has shown mutations which have been not witnessed by the globe before. The more we are encountering the, virus the more complications are coming forward. The example of which is COVID-19 second wave which was more devastating than the first wave; the Indian scenario during even worst. The mortality rates a level checked hospitalized patients was 10.5% which was about 40% higher than 7.2% mortality rate among the patients hospitalized during the pandemic first wave which was a situation of mourn in the country. The major contributing factor for this was the occurrence of cytokine storm. However, the association between factors and parameters that lead to the production of cytokine storm have not been studied in depth. Cytokine storm was not easily handleable in many parts of world which contributed to the mortality and morbidity in patients. The lesson learnt from second wave will help us to deal with this panic of the 3rd wave pandemic situation across the world. The present study is the first Indian study to highlights the impact of simple clinical which include fever and Lymphocyte count on cytokine storm diagnosis. To the best of our knowledge, present study is the first which establishes the role of fever and Lymphopenia as earliest biomarkers of cytokine storm. This study is of significance because if early intervention of cytokine storm is done effectively then we can overcome the complications of COVID-19 infection. A cheap, easily acquired biomarker is needed to identify severe disease among hospitalized patients at early stages. According to our results, recurrent fever/prolonged fever more than 7 days and low count of Lymphocyte are earliest markers for the forthcoming cytokine storm. Hence, recommends the study the use of fever and Lymphocyte count to start the interventions and not wait for the upregulations of IL-6 and down regulation of SpO2 which occurs in late stage.
After a few years of basic analysis, regenerative drugs (RM) are currently commencing to represent a valuable tool to cure many clinical conditions in each acute injuries and chronic diseases. The aim of this study is to update readers on current clinical applications of some selected organs and pathologies which can take pleasure in RM. an in depth literature analysis was performed mistreatment PubMed, Google and specialized journals. RM has achieved nice successes, however there are a unit still many challenges to tackle before it may well be used on a daily in clinical apply. The crucial purpose of this revolution is diagrammatical by the suitable and valid translation from bench to side.
Regenerative medication (RM), from tissue engineering (TE) to cell medical aid, offers valuable treatment choices that are seldom thought-about in daily clinical settings. Doctors, surgeons, clinicians and, in general, care policies aren't at risk of substitute typical approaches with innovative therapies while not extended and thorough experiments. a serious concern that limits the spreading of RM is said to totally different challenges to unravel definitively, e.g. live tissue handling and producing.
Valvular interstitial cells (qVICs) taking after fibroblasts. In sick valves, a myofibroblastic aggregate, actuated VICs (aVICs), is exceptionally proliferative, blend extracellular lattice and fix/rebuild the valve. Grown-up valves additionally have an understudied little populace of ancestor cells (pVIC), which can separate into other VIC aggregates. A superior arrangement is required for the job of pVIC in valvular pathophysiology. We theorize that pVICs intervene deactivation of VICs, to control or forestall obsessive turn of events. Techniques: In this investigation, we confined two subpopulations of pVICs, Mesenchymal Stem Cells (MSC) and Hematopoietic Stem Cells (HSC), and assessed their job in myofibroblastic deactivation of VICs. Porcine pVIC subpopulations were attractively disengaged with CD90 and CD34 individually filling in as markers of MSC and HSC. MSC and HSC subpopulations were approved utilizing optional MSC and HSC markers CD105 and CD117 separately. Three culture types were planned. A pVIC-enhanced culture was made by expanding pVIC focus in VIC populace by half (positive reaction) Native culture kept up with pVIC fixation indistinguishable from local valves postharvest (physiologic reaction). Negative culture had pVICs taken out (negative reaction). Enhanced culture with MSC subpopulation didn’t have any impact on VIC actuation. Enhanced culture with HSC subpopulation actuated deactivation in VICs. End: as far as anyone is concerned, this is one of the principal perceptions of pVIC subpopulations intervening myofibroblastic deactivation in VICs and further investigations are required for a more itemized comprehension of pVIC work in valvular science.
To correlate the level of Hemoglobin A1c (HbA1c) to severity of COVID-19 infection in patients with diabetes. Based on demographic characteristics, at greater risk of complications and death caused by COVID-19 in old age people. We have collected the data and analysed using electronic medical records system based on the conditions such as Demographic and Clinical characteristics like Age, Gender, HbA1c level and comorbid conditions such as Heart problems, Hypertension, Dyslipidemia, Transplant and Tuberculosis disease etc. To overcome this situation, we have described here the correlation of Hemoglobin A1c (HbA1c) levels and COVID-19 severity as determined by group of patients with diabetes tested and hospitalized. Totally, we have investigated 120 COVID-19 patients for the study and 102 were hospitalized. In a Multivariate regression analysis, we have found that No. of male patients were hospitalized higher when compared with female from baseline characteristics of HbA1c levels and also comorbid conditions such as hypertension, heart problems, Thyroid and Dyslipidemia showed higher risk of hospitalization associated with diabetes were statistically significant (p < 0.05), but not for Transplant and Tuberculosis conditions. Primary outcome of the study suggested that prognosis of COVID-19 severity in diabetic patients showed that increased risk based on the level of HbA1c ≥ 9%. Pre-comorbid risk factors useful for management of this disease associated with diabetes patients and minimize the socioeconomic burden with sensitivity approach.
Regeneration is that the activity of replacement or restoring broken or missing cells, tissues, organs, and even entire body components to full operate in plants and animals. Scientists are finding out regeneration for its potential uses in medication, like treating a range of injuries and diseases.
Regenerative medication – which is being attempted essentially in osteoarthritis (OA) - has two branches. One is tissue designing, which attempts to make substitutions for harmed tissue. The other is self-mending, which utilizes infusions of undifferentiated cells or blood items to push the body to fix itself. Regenerative treatment is an elective treatment alternative for knee injury patients. Negligibly obtrusive methods like undifferentiated organism and platelet-rich plasma treatments include an outpatient technique performed under neighborhood sedation in the specialist’s office, utilizing the patient’s own grown-up immature microorganisms to assist the knee with recuperating.
The acceleration and the quality of post surgery healing remain a major issue in medical practice. The platelet rich plasma (PRP) has been widely investigated and used in many chirurgical feeld like orthopedics, dermatology, odontology and gynecology due to its properties and simplicity. Despite the increasing number of studies, there is no consensus regarding the classification used for different types of PRP. Other studies have shown that mesenchymal stromal cells (MSC) have been found in human pererefiric blood. The quantity and quality of MSCs found in the PRP, seem to directly influence the healing results. We hypothesize that current PRP protocols are deleterious for MSCs so that it would be more effective to decrease the speed and duration of centrifugation. Thus the objective of our study was to determine the best centrifugation speed and time to optimize the composition of PRP, particularly MSC, platelet and leukocyte concentration. We have shown that peripheral blood could be considered as a source of MSCs for regenerative medicine. We develop the concept of “soft centrifugation” to obtain a higher concentration of MSCs in the PRP from a peripheral blood sample. Our study shows that injectable platelet rich fibrine with mesenchymal stromal cells (IPRF with MSC) is easy and cheap to produce with minimal effort and can be prepared at the point of care.
Stomach aortic aneurysm (AAA), a reformist segmental stomach aortic expansion, is related with high mortality. AAA is portrayed by aggravation, smooth muscle cell (SMC) exhaustion and extracellular lattice (ECM) debasement. Careful intercession and endovascular treatment are prescribed to forestall break of huge AAAs. Shockingly, there is no solid pharmacological specialist accessible to restrict AAA extension. In the previous many years, broad examinations and a collection of progressing clinical preliminaries pointed toward characterizing strong medicines to hinder and even relapse AAA development.
Neovascularization initiated by vascular endothelial development factor (VEGF) addresses an engaging methodology for treating ischemic coronary illness. Nonetheless, VEGF treatment has been related with transient helpful impacts and likely danger for hemangioma development. Grown-up mesenchymal foundational microorganisms (MSCs) got from bone marrow are a promising hotspot for tissue recovery and fix. To accomplish a protected and tenacious angiogenic impact, we have investigated the capability of autologous MSCs transplantation to improve angiogenesis and cardiovascular capacity of ischemic hearts. Multi week after myocardial localized necrosis initiated by impediment of left front plunging course, autologous MSCs extended in vitro was administrated intramyocardially into the infarct space of a similar contributor rodents. By 2 months, MSCs implantation fundamentally raised VEGF articulation levels, joined by expanded vascular thickness and territorial blood stream in the infarct zone. The neovascularization brought about a diminished apoptosis of hypertrophied myocytes and especially worked on the left ventricular contractility (discharge division: 79.9 ± 7.6% versus 37.2 ± 6.9% in control creatures). In this manner, systems fundamental MSCs improvement of heart capacities may include neovascularization initiated by separation of MSCs to endothelial cells and para-emission of development factors, notwithstanding the apoptosis decrease and recently revealed cardiomyocytes recovery. Two months after cell transplantation, there are huge improvement of left ventricular capacity. Subsequently, autologous MSCs transplantation may address a promising helpful system liberated from moral concerns and invulnerable dismissal, for neovascularization in ischemic heart sicknesses.
Cellular senescence is a stress response and a permanent state of cell cycle arrest of normal cell division. SENEBLOC is involved in both oncogenic and replicative senescence and has been identified as a c-Myc responsive lncRNA involved in senescence. SENEBLOC acts to restrains p21-mediated senescence. Mouse double minute 2 (MDM2) regulates p53, controls its transcriptional activity and protein stability. Cyclin-dependent kinase (CDK) inhibitor p21 promotes cell cycle arrest in response to a variety of stimuli and it can be induced by both p53-dependent and p53-independent mechanisms. SENEBLOC is shown to drive both p53-dependent and p53-independent mechanisms. SENEBLOC acts as a scaffold to promote p53 turnover. It decreases p21 transactivation and promotes p53 and MDM2 association. p53-independent regulation of p21 by SENEBLOC occurs via regulatory effects on HDAC5. Rapamycin promotes SENEBLOC transcription through effects on E2F1. In this review, I focus on the importance of the newly identified LncRNA SENEBLOC
Regenerative medication mistreatment autologous stem cells has the potential to effectively treat acute and chronic wounds related to burns and diabetes; heal wounds quicker and a lot of utterly while not additional tissue graft or surgeries; and prevents serious complications, like infection and amputation. Somatic cell medical care has emerged as a promising treatment modality, with the potential to revive tissue to its pre-injured state. Of explicit interest area unit mesenchyme stromal cells, that are shown to accelerate wound healing by modulating the immunologic response and promoting ontogeny
Exosomes are recently discovered biological nanoparticles (50- 150 nm) that contain signaling cargo pertinent to paracrine cellular signalling within all tissue systems of the human body. Once thought of as cellular debris, exosomes have demonstrateda vast array of applications significant to both the medical and regenerative fields. These extracellular vesicles are secreted from cells as larger multivesicular bodies undergo exocytosis following endosomal processing. Exosome detection in bodily fluids during disease progression has demonstrated potential application as an early-detection disease biomarker. Furthermore, exosomes have been shown to upregulate regenerative effects, such as tissue repair and angiogenesis, in tissue microstructures. Due to the size and bioengineering versatility, exosomes have been the subject of extensive research into targeted drug and gene delivery system development. This minireview aims to characterize both the composition and reported functions of exosomes in addition to potential applications of this technology.
Tissue regeneration includes delivering specific forms of cells or cell product to burned tissues or organs for restoration of tissue and organ operate. Vegetative cell medical aid has drawn right smart attention since transplantation of stem cells will overcome the constraints of autologous transplantation of patient’s tissues; but, it's not good for treating diseases. to beat the hurdles related to vegetative cell medical aid, tissue engineering techniques are developed. Development of vegetative cell technology together with tissue engineering has opened new ways that of manufacturing built tissue substitutes. Many studies have shown that this mixture of tissue engineering and vegetative cell technologies enhances cell viability, differentiation, and therapeutic effectualness of transplanted stem cells.
Autologous cell-based tissue engineering may offer new opportunities for the treatment of long bone defects. Experimental work in small animal models requires an important up scaling to meet the dimensions of geometrically large bone segments that need reconstruction, and this is of uttermost importance to make tissue-engineered cell-based therapies work in clinical conditions. Many fragmentary results in laboratory conditions using mice or rats are described, but a framework for a stepwise up scaling is lacking. Nevertheless, this is essential to guide the preclinical process to a reliable outcome and hence needs to be included in the translational research strategy to lead to predictive results in patients. A structured flowchart provides insight in the progress of the development of a robust tissue-engineered product, the process to reach the clinic, and the critical funding to support this translational step.
